Company Profiles

driven by the PitchBook Platform

CellXplore

CellXplore
2007 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$500K LATEST DEAL AMOUNT
1 INVESTORS
Description

Operator of a technology platform intended to facilitate the discovery of biomarkers. The company's technology platform is into identifying biomarkers for non-invasive diagnosis of breast cancer using biochemical analysis of blood samples, enabling clients to classify disease-specific biomarkers and target for drug discovery in human diseases and also apply it in the field of animal science.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 120 Albany Street, Tower II
  • Suite 850
  • New Brunswick, NJ 08901
  • United States

+1 (732) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CellXplore’s full profile, request a free trial.

CellXplore Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Oct-2007 $500K 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

CellXplore Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Foundation Venture Capital Group Venture Capital Minority 000 0000 000000 0

CellXplore Executive Team (1)

Name Title Board
Seat
Contact
Info
Kiran Madura Ph.D Founder, Chief Scientific Officer & Board Member

CellXplore Board Members (3)

Name Representing Role Since Contact
Info
James Golubieski Foundation Venture Capital Group Board Member 000 0000
Kiran Madura Ph.D CellXplore Founder, Chief Scientific Officer & Board Member 000 0000
Vincent Smeraglia Self Board Observer 000 0000